Page 124 - TD-3-3
P. 124

Tumor Discovery                                                    CRMO presenting as multifocal bone LCH



               doi: 10.1586/1744666X.2013.824670               9.   Wipff J, Costantino F, Lemelle I, et al. A large national cohort
                                                                  of French patients with chronic recurrent multifocal osteitis.
            2.   Zhao DY, McCann L, Hahn G, Hedrich CM. Chronic
               nonbacterial osteomyelitis (CNO) and chronic recurrent   Arthritis Rheumatol. 2015;67(4):1128-1137.
               multifocal osteomyelitis (CRMO).  J  Transl Autoimmun.      doi: 10.1002/art.39013
               2021;4:100095.
                                                               10.  Iyer RS, Thapa MM, Chew FS. Chronic recurrent
               doi: 10.1016/j.jtauto.2021.100095                  multifocal osteomyelitis: Review.  AJR Am J Roentgenol.
                                                                  2011;196(6 Suppl):S87-S91.
            3.   Cox AJ, Ferguson PJ. Update on the genetics of nonbacterial
               osteomyelitis in humans.  Curr Opin Rheumatol.      doi: 10.2214/AJR.09.7212
               2018;30(5):521-525.
                                                               11.  Schnabel A, Range U, Hahn G, Berner R, Hedrich CM.
               doi: 10.1097/BOR.0000000000000530                  Treatment response and  longterm  outcomes  in children
                                                                  with chronic nonbacterial osteomyelitis.  J  Rheumatol.
            4.   Hofmann SR, Morbach H, Schwarz T, Rösen-Wolff A,
               Girschick HJ, Hedrich CM. Attenuated TLR4/MAPK     2017;44(7):1058-1065.
               signaling in monocytes from patients with CRMO results in      doi: 10.3899/jrheum.161255
               impaired IL-10 expression. Clin Immunol. 2012;145(1):69-76.
                                                               12.  Borzutzky A, Stern S, Reiff A, et al. Pediatric chronic nonbacterial
               doi: 10.1016/j.clim.2012.07.012                    osteomyelitis. Pediatrics. 2012;130(5):e1190-e1197.
            5.   Hofmann SR, Kapplusch F, Girschick HJ,  et al.      doi: 10.1542/peds.2011-3788
               Chronic recurrent multifocal osteomyelitis (CRMO):   13.  Ramachandran S, Zhao Y, Ferguson PJ. Update on
               Presentation, pathogenesis, and treatment. Curr Osteoporos   treatment responses and outcome measure development in
               Rep. 2017;15(6):542-554.
                                                                  chronic nonbacterial osteomyelitis.  Curr Opin Rheumatol.
               doi: 10.1007/s11914-017-0405-9                     2023;35(5):255-264.
            6.   Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and      doi: 10.1097/BOR.0000000000000954
               chronic “Symmetrical” osteomyelitis.  Ann Radiol (Paris).   14.  Zhao Y, Wu EY, Oliver MS, et al. Consensus treatment plans for
               1972;15(3):329-342.
                                                                  chronic nonbacterial osteomyelitis refractory to nonsteroidal
            7.   Rukavina I. SAPHO syndrome: A  review.  J  Child   antiinflammatory drugs and/or with active spinal lesions.
               Orthop. 2015;9(1):19-27.                           Arthritis Care Res (Hoboken). 2018;70(8):1228-1237.
               doi: 10.1007/s11832-014-0627-7                     doi: 10.1002/acr.23462
            8.   Roderick MR, Shah R, Rogers V, Finn A, Ramanan   AV.   15.  Hedrich CM, Beresford MW, Dedeoglu F, et al. Gathering
               Chronic    recurrent  multifocal  osteomyelitis    expert consensus to inform a proposed trial in chronic
               (CRMO)  -  Advancing the diagnosis.  Pediatr Rheumatol   nonbacterial  osteomyelitis  (CNO).  Clin  Immunol.
               Online J. 2016;14(1):47.                           2023;251:109344.
               doi: 10.1186/s12969-016-0109-1                     doi: 10.1016/j.clim.2023.109344






























            Volume 3 Issue 3 (2024)                         6                                 doi: 10.36922/td.3102
   119   120   121   122   123   124   125   126